Protein analysis Protoarray

By External Press Release Author
Tuesday, 16 September, 2008


Invitrogen Corporation has launched the ProtoArray Human Protein Microarray v4.1 which enables customers to screen biological samples or labeled probe of interest against approximately 8,200 unique human proteins in as little as one day. This technology has a broad range of applications - identification of novel protein biomarkers specific for infectious diseases, cancers, and autoimmune diseases; mapping protein-protein interactions important to biochemical pathways; identification of kinase/ ubiquitin ligase substrates for target discovery and validation; antibody specificity profiling for research and therapeutic antibody development; and small molecule-protein radioligand profiling for drug candidate selection and development Invitrogen Tel: 1800 331 627 www.invitrogen.com/protoarray.

Related Articles

Shingles vaccine may lower risk of dementia, heart disease

It turns out that the shingles vaccine may have public-health benefits beyond its intended...

How does the brain evaluate rewards?

Neuroscientists have shown how nerve cells in the amygdala not only encode the probability and...

Breakthrough drug prevents long COVID symptoms in mice

Mice treated with the antiviral compound were protected from long-term brain and lung dysfunction...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd